Showing 501 - 520 results of 42,865 for search '(( 50 ((we decrease) OR (nn decrease)) ) OR ( 16 ((teer decrease) OR (a decrease)) ))', query time: 1.02s Refine Results
  1. 501
  2. 502
  3. 503
  4. 504
  5. 505
  6. 506
  7. 507
  8. 508
  9. 509

    Isolation of a Genomic Region Affecting Most Components of Metabolic Syndrome in a Chromosome-16 Congenic Rat Model by Lucie Šedová (641578)

    Published 2016
    “…We derived the SHR.BN16 congenic strain by introgression of a limited RNO16 region from the Brown Norway congenic strain (BN-<i>Lx</i>) into the genomic background of the spontaneously hypertensive rat (SHR) strain. …”
  10. 510
  11. 511
  12. 512
  13. 513
  14. 514
  15. 515
  16. 516

    Neither G9a nor SUV39H1 knockdown affects gene expression and epigenetic states of p16 and RASSF1A. by Yutaka Kondo (35816)

    Published 2008
    “…In contrast to 5-Aza-2′-deoxycytidine (DAC) treatment, neither G9a-KD nor SUV-KD reactivates p16 and RASSF1A expression. p21 and GAPDH are used for active gene controls. …”
  17. 517
  18. 518
  19. 519

    Sinupret is a robust activator of CFTR-mediated and calcium-activated Cl<sup>-</sup> secretion. by Shaoyan Zhang (363713)

    Published 2014
    “…There were significant decreases in I<sub>SC</sub> when cultures were treated with CFTR inhibitor INH-172 in WT MNSE (−16.1+/−1.3 vs. −6.5+/−0.7, p<0.05) and HSNE cells (−17.0+/−1.6 vs. −11.1+/−1.7, p<0.05).…”
  20. 520

    Homologs of 16p12.1 genes contribute towards neurodevelopmental defects through weak genetic interactions and combined independent effects. by Lucilla Pizzo (2735491)

    Published 2021
    “…<p>(<b>A</b>) We generated eye-specific <i>GMR-GAL4</i> recombinant lines for the four 16p12.1 homologs to test a total of twelve pairwise interactions for modulation of eye defects. …”